{ "items": [ "\n\n
\n \n 10 December 2020\n \n
\n\n \n\n \n\n \n \n \n \n Awards\n \n \n \n \n General\n \n \n\n \n\n\n
\n \n\n \n \n \nFive new Oxford-Bristol Myers Squibb Fellowships representing an investment of \u00a33M have been announced. The fellowships (formerly Oxford-Celgene) will support postdoctoral researchers and clinicians across five departments within the Medical Sciences Division and the Mathematical, Physical and Life Sciences Division, providing an opportunity for them to gain exposure to the field of commercial drug discovery and development.
\n \n\n\n \n 25 November 2020\n \n
\n\n \n \n \n\n \n \n \nPeople with Rheumatoid Arthritis (RA) could soon benefit from a new drug treatment that not only suppresses inflammation but also significantly reduces patient reported pain scores. Otilimab is a monoclonal antibody, biologic drug, which targets and suppresses the inflammatory cytokine GM-CSF.
\n \n\n\n \n 24 November 2020\n \n
\n\n \n\n \n\n \n \n \n \n Awards\n \n \n\n \n\n\n
\n \n\n \n \n \nAn Oxford team from the Centre for Medicines Development, Department of Physiology Anatomy and Genetics and Radcliffe Department of Medicine led by Professor Jagdeep Nanchahal at the Kennedy Institute has been awarded a Wellcome Innovator Award to develop a first in class therapeutic aimed at regenerating heart muscle after heart attack.
\n \n\n\n \n 19 November 2020\n \n
\n\n \n\n \n\n \n \n \n \n Awards\n \n \n\n \n\n\n
\n \n\n \n \n \nProfessor Gary Collins, Professor Cyrus Cooper, Professor Fiona Powrie and the late Professor Doug Altman have been named on the annual Highly Cited Researchers\u2122\ufe0f 2020 list from Clarivate.
\n \n\n\n \n 13 November 2020\n \n
\n\n \n\n \n\n \n \n \n \n Awards\n \n \n\n \n\n\n
\n \n\n \n \n \nProfessor Simon has been successful in her Wellcome Trust Investigator Award entitled: \u201cProteostasis and Autophagy in Immune Senescence.\u201d
\n \n\n\n \n 5 November 2020\n \n
\n\n \n\n \n\n \n \n \n \n Awards\n \n \n\n \n\n\n
\n \n\n \n \n \nThree NDORMS researchers have been awarded new titles in the University of Oxford's 2020 Recognition of Distinction exercise.
\n \n\n\n \n 3 November 2020\n \n
\n\n \n\n \n\n \n \n \n \n Awards\n \n \n\n \n\n\n
\n \n\n \n \n \nNDORMS has been designated a EULAR Centre of Excellence 2020-2025, in recognition of our continued high-quality research publications in rheumatology.
\n \n\n\n \n 30 October 2020\n \n
\n\n \n \n \n\n \n \n \nIn a collaboration with scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), Kennedy researchers have contributed to the discovery that neutrophils have many more functions in the body than previously thought. This finding suggests that neutrophil tissue-specific plasticity could be exploited in designing new treatments for neutrophil driven diseases, including cancer.
\n \n\n\n \n 23 October 2020\n \n
\n\n \n \n \n\n \n \n \nProfessor Marco Fritzsche has joined the Kennedy Institute as the Principal Investigator of the Biophysical Immunology Laboratory (BPI), as part of a joint appointment with the Rosalind Franklin Institute. His lab is leading the development of a lattice light sheet microscope that will significantly advance the study of live cells.
\n \n\n\n \n 20 October 2020\n \n
\n\n \n \n \n\n \n \n \nA team from the University of Oxford has visualised how key cells of the immune system lock onto cancerous or infected cells to destroy them. The work was led by the Mike Dustin\u2019s group at the Kennedy Institute of Rheumatology and experts in colorectal and ovarian cancers from across Oxford and computational biologists at the University of Birmingham.
\n \n\n\n \n 19 October 2020\n \n
\n\n \n \n \n\n \n \n \nNDORMS researchers identify a subset of immune cells that could be a new therapeutic target to treat inflamed blood vessels in Giant Cell Arteritis (GCA) and other forms of inflammatory vascular disease.
\n \n\n\n \n 9 October 2020\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n\n \n\n\n
\n \n\n \n \n \nDr Rahul Ravindran has been awarded a highly competitive MRC Clinical Research Training Fellowship, following a successful research placement at the Kennedy Institute in 2019.
\n \n\n\n \n 2 October 2020\n \n
\n\n \n \n \n\n \n \n \nResearchers at the Kennedy Institute review the growing body of literature on the role of the microbiome in colorectal cancer
\n \n\n\n \n 18 August 2020\n \n
\n\n \n \n \n\n \n \n \n \n \n\n\n \n 23 July 2020\n \n
\n\n \n\n \n\n \n \n \n \n Awards\n \n \n\n \n\n\n
\n \n\n \n \n \nThe University of Oxford has awarded the title of Associate Professor to Kennedy researchers Tal Arnon and Marco Fritzsche.
\n \n\n\n \n 10 July 2020\n \n
\n\n \n \n \n\n \n \n \nCongratulations to Mariana Borsa for being awarded the Marie Sk\u0142odowska-Curie Actions \u2013 Individual Fellowship
\n \n\n\n \n 8 July 2020\n \n
\n\n \n\n \n\n \n \n \n \n General\n \n \n\n \n\n\n
\n \n\n \n \n \nA building project to extend the Kennedy Institute of Rheumatology building with a new floor will create much needed space for the Institute to expand, particularly in the areas of data science and clinical trials.
\n \n\n\n \n 1 July 2020\n \n
\n\n \n \n \n\n \n \n \nProfessor Mark Coles was recently appointed to the governing body of the University\u2019s newest graduate college.
\n \n\n\n \n 29 June 2020\n \n
\n\n \n \n \n\n \n \n \nThe key to swift treatments to cure the pain of rheumatoid arthritis has been found in the joints of people with the condition who are in long- term remission.
\n \n\n\n \n 22 June 2020\n \n
\n\n \n\n \n\n \n \n \n \n Awards\n \n \n\n \n\n\n
\n \n\n \n \n \nRecognised for the part he played in the discovery of anti-TNF therapy, Dr Feldmann is now exploring whether the antibody can be effective for COVID-19.
\n \n\n